サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide 2014-2023

BRIC(ブラジル、ロシア、インド、中国)の製薬業界ガイド 2014-2023

レポート概要

BRICの製薬業界プロファイルは、市場シェア、市場規模(2014~2018年、および2023年までの売上および販売数予測)など、定性および定量サマリー情報を提供します。また、主な財務メトリクス、市場内の競争圧力の分析など、主要企業の概要を含みます。

トップラインのデータや分析には、市場規模やセグメントデータ、テキスト、および市場成長動向や主要企業のグラフィック分析を含みます。

  • ブラジル、ロシア、インド、中国(BRIC)は、製薬業界で急成長している新興国であり、2018年の総市場価値は2,193億ドルでした。インドは2014~2018年のCAGRが15.4%で最も成長が著しい国です。
  • 製薬業界では、2018年に中国がBRIC諸国の中でトップクラスの国であり、市場収益は1,329億ドルで、インド、ロシア、ブラジルがそれぞれ382億ドル、245億ドル、236億ドルでした。
  • 2023年、中国はBRIC諸国をリードし、2,347億ドルが見込まれており、インド、ロシア、ブラジルがそれぞれ727億ドル、449億ドル、279億ドルで続くでしょう。

■調査範囲

  • BRICの製薬市場における規模、成長率、および主要企業を特定します。
  • 競争の激しさ、ひいてはBRICの製薬市場の魅力を判断するため、ファイブフォース分析を使用しました。
  • 主要企業概要から、BRICにおける事業および財務実績の詳細を明らかにします。
  • 5年予測でBRICの製薬市場の将来の成長見通しを明らかにします。
  • ブラジル、ロシア、インド、中国のデータを比較します。

レポート詳細

目次

Table of Contents
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
BRIC Pharmaceuticals
Industry Outlook
Pharmaceuticals in Brazil
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in India
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Russia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading Companies
Appendix
Methodology
About MarketLine

List of Tables
Table 1: BRIC pharmaceuticals industry, revenue($bn), 2014-23
Table 2: BRIC pharmaceuticals industry, revenue($bn), 2014-18
Table 3: BRIC pharmaceuticals industry, revenue($bn), 2018-23
Table 4: Brazil pharmaceuticals market value: $ billion, 2014-18
Table 5: Brazil pharmaceuticals market geography segmentation: $ billion, 2018
Table 6: Brazil pharmaceuticals market share: % share, by value, 2018
Table 7: Brazil pharmaceuticals market value forecast: $ billion, 2018-23
Table 8: Brazil size of population (million), 2014-18
Table 9: Brazil gdp (constant 2005 prices, $ billion), 2014-18
Table 10: Brazil gdp (current prices, $ billion), 2014-18
Table 11: Brazil inflation, 2014-18
Table 12: Brazil consumer price index (absolute), 2014-18
Table 13: Brazil exchange rate, 2014-18
Table 14: China pharmaceuticals market value: $ billion, 2014-18
Table 15: China pharmaceuticals market geography segmentation: $ billion, 2018
Table 16: China pharmaceuticals market share: % share, by value, 2018
Table 17: China pharmaceuticals market value forecast: $ billion, 2018-23
Table 18: China size of population (million), 2014-18
Table 19: China gdp (constant 2005 prices, $ billion), 2014-18
Table 20: China gdp (current prices, $ billion), 2014-18
Table 21: China inflation, 2014-18
Table 22: China consumer price index (absolute), 2014-18
Table 23: China exchange rate, 2014-18
Table 24: India pharmaceuticals market value: $ billion, 2014-18
Table 25: India pharmaceuticals market geography segmentation: $ billion, 2018
Table 26: India pharmaceuticals market share: % share, by value, 2018
Table 27: India pharmaceuticals market value forecast: $ billion, 2018-23
Table 28: India size of population (million), 2014-18
Table 29: India gdp (constant 2005 prices, $ billion), 2014-18
Table 30: India gdp (current prices, $ billion), 2014-18
Table 31: India inflation, 2014-18
Table 32: India consumer price index (absolute), 2014-18
Table 33: India exchange rate, 2014-18
Table 34: Russia pharmaceuticals market value: $ billion, 2014-18
Table 35: Russia pharmaceuticals market geography segmentation: $ billion, 2018
Table 36: Russia pharmaceuticals market share: % share, by value, 2018
Table 37: Russia pharmaceuticals market value forecast: $ billion, 2018-23
Table 38: Russia size of population (million), 2014-18
Table 39: Russia gdp (constant 2005 prices, $ billion), 2014-18
Table 40: Russia gdp (current prices, $ billion), 2014-18
Table 41: Russia inflation, 2014-18
Table 42: Russia consumer price index (absolute), 2014-18
Table 43: Russia exchange rate, 2014-18
Table 44: Ache Laboratorios Farmaceuticos SA: key facts
Table 45: Guangzhou Pharmaceutical Holdings Ltd: key facts
Table 46: Shanghai Pharmaceuticals: key facts
Table 47: Shanghai Pharmaceuticals: key financials ($)
Table 48: Shanghai Pharmaceuticals: key financials (CNY)
Table 49: Shanghai Pharmaceuticals: key financial ratios
Table 50: Yangtze River Pharmaceutical Group: key facts
Table 51: Yunnan Baiyao Group Co Ltd: key facts
Table 52: Yunnan Baiyao Group Co Ltd: key financials ($)
Table 53: Yunnan Baiyao Group Co Ltd: key financials (CNY)
Table 54: Yunnan Baiyao Group Co Ltd: key financial ratios
Table 55: Aurobindo Pharma Limited: key facts
Table 56: Aurobindo Pharma Limited: key financials ($)
Table 57: Aurobindo Pharma Limited: key financials (Rs.)
Table 58: Aurobindo Pharma Limited: key financial ratios
Table 59: Dr. Reddy's Laboratories Limited: key facts
Table 60: Dr. Reddy's Laboratories Limited: key financials ($)

List of Figures
Figure 1: BRIC pharmaceuticals industry, revenue($bn), 2014-23
Figure 2: BRIC pharmaceuticals industry, revenue($bn), 2014-18
Figure 3: BRIC pharmaceuticals industry, revenue($bn), 2018-23
Figure 4: Brazil pharmaceuticals market value: $ billion, 2014-18
Figure 5: Brazil pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 6: Brazil pharmaceuticals market share: % share, by value, 2018
Figure 7: Brazil pharmaceuticals market value forecast: $ billion, 2018-23
Figure 8: Forces driving competition in the pharmaceuticals market in Brazil, 2018
Figure 9: Drivers of buyer power in the pharmaceuticals market in Brazil, 2018
Figure 10: Drivers of supplier power in the pharmaceuticals market in Brazil, 2018
Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2018
Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2018
Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2018
Figure 14: China pharmaceuticals market value: $ billion, 2014-18
Figure 15: China pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 16: China pharmaceuticals market share: % share, by value, 2018
Figure 17: China pharmaceuticals market value forecast: $ billion, 2018-23
Figure 18: Forces driving competition in the pharmaceuticals market in China, 2018
Figure 19: Drivers of buyer power in the pharmaceuticals market in China, 2018
Figure 20: Drivers of supplier power in the pharmaceuticals market in China, 2018
Figure 21: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2018
Figure 22: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2018
Figure 23: Drivers of degree of rivalry in the pharmaceuticals market in China, 2018
Figure 24: India pharmaceuticals market value: $ billion, 2014-18
Figure 25: India pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 26: India pharmaceuticals market share: % share, by value, 2018
Figure 27: India pharmaceuticals market value forecast: $ billion, 2018-23
Figure 28: Forces driving competition in the pharmaceuticals market in India, 2018
Figure 29: Drivers of buyer power in the pharmaceuticals market in India, 2018
Figure 30: Drivers of supplier power in the pharmaceuticals market in India, 2018
Figure 31: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2018
Figure 32: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2018
Figure 33: Drivers of degree of rivalry in the pharmaceuticals market in India, 2018
Figure 34: Russia pharmaceuticals market value: $ billion, 2014-18
Figure 35: Russia pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 36: Russia pharmaceuticals market share: % share, by value, 2018
Figure 37: Russia pharmaceuticals market value forecast: $ billion, 2018-23
Figure 38: Forces driving competition in the pharmaceuticals market in Russia, 2018
Figure 39: Drivers of buyer power in the pharmaceuticals market in Russia, 2018
Figure 40: Drivers of supplier power in the pharmaceuticals market in Russia, 2018
Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2018
Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2018
Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2018
Figure 44: Shanghai Pharmaceuticals: revenues & profitability
Figure 45: Shanghai Pharmaceuticals: assets & liabilities
Figure 46: Yunnan Baiyao Group Co Ltd: revenues & profitability
Figure 47: Yunnan Baiyao Group Co Ltd: assets & liabilities
Figure 48: Aurobindo Pharma Limited: revenues & profitability
Figure 49: Aurobindo Pharma Limited: assets & liabilities
Figure 50: Dr. Reddy's Laboratories Limited: revenues & profitability
Figure 51: Dr. Reddy's Laboratories Limited: assets & liabilities
Figure 52: Lupin Ltd: revenues & profitability
Figure 53: Lupin Ltd: assets & liabilities
Figure 54: Sun Pharmaceutical Industries Ltd: revenues & profitability
Figure 55: Sun Pharmaceutical Industries Ltd: assets & liabilities
Figure 56: Bayer AG: revenues & profitability
Figure 57: Bayer AG: assets & liabilities
Figure 58: Novartis AG: revenues & profitability
Figure 59: Novartis AG: assets & liabilities
Figure 60: Sanofi SA: revenues & profitability

発刊日

2019/04/29

体裁

PDF / 115ページ

販売価格

995USD

発行

MarketLine

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医薬品産業(医療制度、医療観光など)

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE